Circulation, Vol 83, 1873-1879, Copyright © 1991 by American Heart Association
MA Creager, RJ Quigg, CJ Ren, MA Roddy and WS Colucci
BACKGROUND. In patients with congestive heart failure, the chronotropic and
inotropic responses to beta-adrenergic agonists are reduced. It is not
known whether desensitization of peripheral beta-adrenoceptors accounts for
impaired limb vasodilation in these patients. Accordingly, we studied 14
normal subjects and 13 age-matched patients with congestive heart failure.
METHODS AND RESULTS. To distinguish vasodilation mediated by
beta-adrenoceptors and adenylate cyclase from that mediated by stimulation
of guanylate cyclase, each subject received intrabrachial artery infusions
of isoproterenol (1-100 ng/min) and sodium nitroprusside (0.3-10
micrograms/min), respectively. Forearm blood flow was determined by venous
occlusion plethysmography. Maximal vasodilative potential, determined
during reactive hyperemia, was reduced in the patients with congestive
heart failure. The maximal forearm blood flow response to isoproterenol was
comparable in patients with heart failure and in normal subjects (8.0 +/-
1.1 versus 9.2 +/- 1.2 ml/100 ml of tissue/min, respectively, p = NS).
Furthermore, the dose-response relation to isoproterenol was similar in
both groups. Likewise, the forearm vasodilative response to sodium
nitroprusside was preserved in the heart failure group. Plasma
concentration of norepinephrine was higher in the patients with heart
failure (436 +/- 34 versus 201 +/- 74 pg/ml, p less than 0.01). When both
groups were considered, there was no correlation between norepinephrine
levels and the maximal forearm blood flow response to isoproterenol (r =
0.10, p = NS). CONCLUSIONS. We conclude that beta-adrenoceptor
desensitization does not occur in the limb vessels of patients with
congestive heart failure.
ARTICLES
Limb vascular responsiveness to beta-adrenergic receptor stimulation in patients with congestive heart failure
Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115.
This article has been cited by other articles:
![]() |
J. Cui, A. Arbab-Zadeh, A. Prasad, S. Durand, B. D. Levine, and C. G. Crandall Effects of Heat Stress on Thermoregulatory Responses in Congestive Heart Failure Patients Circulation, October 11, 2005; 112(15): 2286 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakamura, H. Yoshida, Y. Naganuma, H. Kon, S. Sugawara, and K. Hiramori Peripheral Vasodilatory Dysfunction in Adult Patients with Congenital Heart Disease and Severely Elevated Pulmonary Vascular Resistance Angiology, November 1, 2002; 53(6): 715 - 720. [Abstract] [PDF] |
||||
![]() |
S. D. Katz, K. Balidemaj, S. Homma, H. Wu, J. Wang, and S. Maybaum Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure J. Am. Coll. Cardiol., September 1, 2000; 36(3): 845 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Stein, R. Nelson, R. Deegan, H. He, T. Inagami, M. Frazer, K. F. Badr, M. Wood, and A. J. J. Wood Tachyphylaxis of Human Forearm Vascular Responses Does Not Occur Rapidly After Exposure to Isoproterenol Hypertension, June 1, 1995; 25(6): 1294 - 1300. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |